基本信息
浏览量:0
职业迁徙
个人简介
Research priorities: Oxidation, Oxygen homeostasis, Tumour hypoxia
Peter J. Ratcliffe is a British nephrologist. Ratcliffe discovered how the cells of the human body sense and adapt to oxygen availability. This discovery has provided the basis for developing new strategies to combat anaemia, cancer, and other diseases. For his research, Peter J. Ratcliffe was honoured with the 2019 Nobel Prize in Physiology or Medicine.
Maintaining oxygen balance (oxygen homeostasis) is a key challenge for the body. Oxygen deficiency (hypoxia) is a major cause of many diseases. Oxygen availability affects, for example, the growth of cancer cells in certain cases.
Oxygen sensors of cells offer starting points for developing new therapies to treat cancer, anaemia, and lung and cardiovascular diseases. The reason being that in cancer, many of these signaling pathways are dysregulated by either an oncogenic mutation or microenvironmental hypoxia. Peter Ratcliffe's lab investigates the importance of these processes for disease development, particularly the effects of unphysiological switching of massively interconnected signaling pathways in cancer.
Ratcliffe's researchers want to understand how these pathways' potentially anti-oncogenic components are adapted during cancer progression. Lineage marking and genetic and genomic strategies are being used to do so.
Peter J. Ratcliffe is a British nephrologist. Ratcliffe discovered how the cells of the human body sense and adapt to oxygen availability. This discovery has provided the basis for developing new strategies to combat anaemia, cancer, and other diseases. For his research, Peter J. Ratcliffe was honoured with the 2019 Nobel Prize in Physiology or Medicine.
Maintaining oxygen balance (oxygen homeostasis) is a key challenge for the body. Oxygen deficiency (hypoxia) is a major cause of many diseases. Oxygen availability affects, for example, the growth of cancer cells in certain cases.
Oxygen sensors of cells offer starting points for developing new therapies to treat cancer, anaemia, and lung and cardiovascular diseases. The reason being that in cancer, many of these signaling pathways are dysregulated by either an oncogenic mutation or microenvironmental hypoxia. Peter Ratcliffe's lab investigates the importance of these processes for disease development, particularly the effects of unphysiological switching of massively interconnected signaling pathways in cancer.
Ratcliffe's researchers want to understand how these pathways' potentially anti-oncogenic components are adapted during cancer progression. Lineage marking and genetic and genomic strategies are being used to do so.
研究兴趣
论文共 5 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Betty Gardie,Sophie Couvé,Charline Ladroue,Elodie Laine,Karène Mahtouk,Justine Guegan,Sophie Gad, Hélène Le Jeune, Bernard Lecomte, Jean-Christophe Pagès, Patrick R. Benusiglio,Brigitte Bressac-de Paillerets,
引用23浏览0引用
23
0
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn